Company profile for Enterin

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Enterin Inc. is a clinical-stage biopharmaceutical company pioneering novel treatments that target the gut-brain axis and modify the course of neurodegenerative disorders. Our research has aided the scientific community in understanding the link between infection and the role of the enteric nervous system (ENS) in immune defense. As a result of repeated insults to the gastrointestinal tract (GIT), neural communication between ...
Enterin Inc. is a clinical-stage biopharmaceutical company pioneering novel treatments that target the gut-brain axis and modify the course of neurodegenerative disorders. Our research has aided the scientific community in understanding the link between infection and the role of the enteric nervous system (ENS) in immune defense. As a result of repeated insults to the gastrointestinal tract (GIT), neural communication between the ENS and the central nervous system (CNS) is progressively impaired. Our work has clarified the relationship between immune defense, the ageing process, and the progression of neurodegeneration.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
2005 Market Street, Suite 3125 Philadelphia, PA 19103
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/11/26/2987886/0/en/MUSE-Microscopy-Inc-is-Entering-a-New-Era-of-Digital-Pathology-with-the-Development-of-the-SmartPath-MUSE-Technology-SmartPath-Imager.html

GLOBENEWSWIRE
26 Nov 2024

https://www.expresspharma.in/strategic-approaches-for-pharma-companies-entering-the-nutraceutical-sector/

EXPRESSPHARMA
07 Oct 2024

https://www.prnewswire.com/news-releases/scinai-announces-entering-into-2-million-private-equity-commitment-agreement-with-its-largest-existing-shareholder-302226460.html

PR NEWSWIRE
20 Aug 2024

https://www.businesswire.com/news/home/20240717918840/en

BUSINESSWIRE
17 Jul 2024

https://www.prnewswire.com/news-releases/willow-announces-collaboration-with-enterin-to-develop-sustainable-intermediates-and-active-pharmaceutical-ingredients-302035457.html

PR NEWSWIRE
16 Jan 2024

https://www.globenewswire.com/news-release/2023/06/05/2681900/0/en/Enterin-Announces-the-Start-of-a-First-in-Human-Study-of-ENT-03-in-Obesity-and-Type-2-Diabetes.html

GLOBENEWSWIRE
05 Jun 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty